Navigation Links
Telomere Biosciences Announces: TELO-100 with T-Activator 150, a Breakthrough in Telomere Science and Age Management
Date:11/21/2013

COLD SPRING, N.Y., Nov. 21, 2013 /PRNewswire/ -- Telomere Biosciences, LLC. (Telomere Biosciences) announced today the launch of their Nutraceutical "TELO-100 with T-Activator 150"™, the first and only supplement in the world to target all major causes of Telomere shortening, to help promote and extend human healthspan. Telomeres are the protective caps at the ends of every chromosome in the body. A wealth of ground-breaking research by some of the world's leading experts in Telomere Science and Aging, including Nobel laureates, has demonstrated a strong connection between short Telomeres and many of the negative conditions associated with human aging.  

"Telomere Biosciences is excited and proud to launch TELO-100 with T-Activator 150," said David B. Cross, founder of Telomere Biosciences. "And while TELO-100 includes 9 natural compounds documented to activate the Telomere-lengthening enzyme, telomerase, TELO-100 is much more than just a telomerase activator, however, as the latest research in Telomere Science through 2013 shows conclusively that there are several key factors which lead to Telomere shortening, all of which should be addressed to have the greatest positive impact on Telomere length."

At a recent conference of leading Age Management Medicine Physicians, Dr. Keith Fleischman gave the following summary: "Oxidative stress, inflammation, and increased cell renewal accelerate the ongoing shortening of chromosomal telomeres...Through attention to reducing accelerants of telomere shortening and through the use of supporters and activators of telomerase activity we may be able to exert influence" over many physiologic processes related to aging.

With its integrated "complex" of 17 pro-Telomere ingredients, TELO-100 is the first and only Nutraceutical to target not only telomerase activation ('TA'), but also the other major causes of Telomere shortening--including oxidative stress, inflammation, homocysteine, and the 'stress-hormone' cortisol--in one comprehensive Telomere product.

"The Mission of Telomere Biosciences is clear," added Cross: "To bring the breakthrough health benefits of Nobel prize-winning Telomere Science to a mass audience globally, applying the very latest research in the field to products like TELO-100, the most advanced Telomere Nutraceutical available. And we are equally committed to making this leading-edge science and product price-accessible not only to the wealthy, but to all those who can benefit from longer Telomeres for a longer healthspan." TELO-100 is available both through Healthcare Practitioners and directly to consumers.

About Telomere Biosciences:
Telomere Biosciences, founded in 2010, is located at 10 North St., Cold Spring, NY, and is privately held. 
For more information on Telomere Biosciences and TELO-100 visit www.TelomereBiosciences.com 
Media Contact: Telomere Biosciences, Info@TelomereBiosciences.com


'/>"/>
SOURCE Telomere Biosciences, LLC.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Telomere Diagnostics, Inc. (TDx), previously known as Telome Health, Inc., announces its name change
2. Stem Cell and Telomere Support Provided by Stem Cell 100 from Life Code
3. Life Length Telomere Test Available Nationwide
4. Sangamo BioSciences Announces Seven Data Presentations At The 2013 American Society of Hematology Annual Meeting
5. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
6. Proove Biosciences to Present Research on the Genetics of Pain Medicine and Exhibit at ASRA’s 12th Annual Pain Medicine Meeting
7. Sangamo BioSciences Announces Presentation Of Clinical Data From Alzheimers Disease Program
8. Ambit Biosciences Announces Third Quarter 2013 Operating Results
9. Pressure BioSciences, Inc. Reports Third Quarter 2013 Financial Results and Provides Business Update
10. Juneau Biosciences Names Dr. Dinesh Patel to Board of Directors
11. Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , February 4, 2016 ... a biotechnology acceleration company is pleased to provide the following ... --> Over the last 3 months we have ... securities purchase agreements exceeding $1,000,000. As a result, we have ... Mannin Research Inc. license agreement and expect that development to ...
(Date:2/4/2016)... Md. , Feb. 4, 2016  Spherix Incorporated ... to the fostering and monetization of intellectual property, today ... and Uniden in the Northern District of ... moving forward.  Inter Partes Re-examination ... U.S. Patent Office.  The IPR was initiated on only ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... leading supplier of Semantic Graph Database technology has been recognized As “ Best ... by Corporate America Magazine. , “At Corporate America, it’s our priority to showcase ...
(Date:2/4/2016)... ... February 04, 2016 , ... Many of the engineers at FireflySci, Inc. ... What sets them apart from other cuvette manufacturers is their supercharged customer service and ... On top of this steady flow of inside information, they have recently revamped their ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... new market research report "Automated Fingerprint Identification System Market ... Latent Search), Application (Banking & Finance, Government, Healthcare, and ... by MarketsandMarkets, the market is expected to be worth ... of 21.0% between 2015 and 2020. The transformation and ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
Breaking Biology News(10 mins):